Retatrutide, a new weight loss medicine. As the only injection to support weight loss in three ways, Retatrutide 40mg pen/injection could be revolutionary in this space.
GLP-1 medication can be stored unrefrigerated at temperatures not above 30 degrees Celsius for up to 30 days.
Store in a refrigerator, do not freeze it.
How does Retatrutide 40mg Pen work?
Retatrutide has been nicknamed ‘Triple G’. This is because it targets three different receptors and hormones GLP-1, glucagon, and GIP. Glucagon and GIP are naturally released when you eat food and play a role in reducing appetite, lowering blood sugar, and helping the body burn fat.
This means Retatrutide can support people to reduce weight in three ways:
- Suppress appetite and slow digestion, meaning you’re not as hungry as often and feel fuller for longer
- Increase fat metabolism, so your body breaks down fat quicker
- Increase insulin sensitivity, which reduces blood sugar, causing the body to break down stored fat
What does Retatrutide 40mg treat?
Retatrutide 40mg pen has been predominantly developed for weight loss for people with obesity and is proving promising.
It might also be used to treat type 2 diabetes. With type 2 diabetes, a person’s insulin either doesn’t work properly, or there is not enough of it, causing blood sugar levels to become too high . This can cause individuals to feel tired and thirsty, lose weight unintentionally, and need to pee more than usual.
Some people can also experience blurred vision, slower healing of cuts and wounds, thrush that keeps coming back, or itching around the penis or vagina. Since Retatrutide targets glucagon receptors, increasing insulin sensitivity and reducing blood sugar, it could be an effective treatment for people with type 2 diabetes.
Investigations into Retatrutide’s effectiveness in fatty liver disease are also underway. Non-alcoholic fatty liver disease (NAFLD) is a term that covers several conditions that are caused by fat building up in the liver.
This usually affects people who are overweight or living with obesity or who have type 2 diabetes. NAFLD can cause the liver to become inflamed, which can lead to scarring and damage, and then even liver failure. Since Retatrutide 40mg Pen/injection may be able to reduce liver fat in people with obesity, it could also prevent the progression of NAFLD.
How is Retatrutide administered?
Retatrutide 40mg is given using a pen injector. It is delivered as a subcutaneous injection into the arm, thigh, or stomach. It is expected to be administered weekly, starting with a lower dose to minimise side effects.
What are the side effects of retatrutide?
Retatrutide has some common side effects, similar to Wegovy and Mounjaro, including:
- Nausea
- Vomiting
- Constipation
- Diarrhoea
Since retatrutide can help increase weight loss in an additional way to Wegovy and Mounjaro, these side effects could be more intense. They can be managed by using the injection when you eat, drinking plenty of water, and getting enough fiber in your diet.
You should always speak to your doctor if you are experiencing any side effects from medication. They can help you manage side effects or suggest a different treatment.
The Retatrutide 40mg box contains:
- 1 Pen of 4 x 10mg doses
- 12 disposable needles
- 1 instruction booklet
Use Once weekly with medical orientation
(Not recommended in any case of pancreatitis problems—always talk to your doctor.)
